It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Lyrica against the benefits it is expected to have for you. Lyrica is used to treat neuropathic pain, which is pain caused by an abnormality of, or damage to, the nerves. Lyrica is also used to control epilepsy. Epilepsy is a condition where you have repeated seizures fits. There are many different types of seizures, ranging from mild to severe.
How likely is it that you would recommend our site to a friend?
Lyrica has an average rating of 6. Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
More about Lyrica (pregabalin)
Currently living in Canada after retiring from being the 77th generation Mahou Shoujo, she is a retired magical girl who has become a VTuber. Due to her age and her fans, Lyrica calls herself a "Lola", the Filipino word for grandmother. She is really wholesome deep down although she may accidentally swear at times. She has a bubbly and cheerful attitude, laughs often, and is adorable. She says in her introduction video that she plays mobile games often but is not good at them. In turn, she went to VTubing as a way for fans to help her. She made her YouTube account on 3 June , and her Twitter account was created on the same month. Her introduction video was uploaded 1 day later on 4 June. On 29 June, she announced the name of the fanbase on a YouTube stream; the fanbase was officially called " Sinigang ". On 8 July, she had her first major collab, in which she played a game with Moona.
On December 19, FDA is warning that serious breathing difficulties may occur in patients using gabapentin brand names Neurontin, Gralise, Horizant or pregabalin brand names Lyrica, Lyrica CR who have respiratory risk factors. These include the use of opioid pain medicines and other drugs that depress the central nervous system or CNS , and conditions such as chronic obstructive pulmonary disease that reduce lung function. The elderly are also at higher risk. Gabapentin and pregabalin are FDA-approved for a variety of conditions, including seizures, nerve pain, and restless legs syndrome. Pregabalin is a Schedule V controlled substance, which means it has a lower potential for abuse among the drugs scheduled by the Drug Enforcement Administration but may lead to some physical or psychological dependence. Our evaluation shows that use of these gabapentinoid medicines, has been growing for prescribed medical use, as well as misuse and abuse. Gabapentinoids are often being combined with CNS depressants, which increases the risk of respiratory depression. There is less evidence supporting the risk of serious breathing difficulties in healthy individuals taking gabapentinoids alone. We are requiring new warnings about the risk of respiratory depression be added to the prescribing information of the gabapentinoids and have required the drug manufacturers to conduct clinical trials to further evaluate their abuse potential, particularly in combination with opioids. Misuse and abuse of these products together is increasing and may increase the risk of respiratory depression.